Literature DB >> 19100699

Homeostasis of naive and memory T cells.

Charles D Surh1, Jonathan Sprent.   

Abstract

The peripheral mature T cell pool is regulated by complex homeostatic mechanisms. Naive T cells are maintained by interleukin-7 (IL-7) and T cell receptor (TCR) signaling from contact with major histocompatibility complex (MHC), which sustain expression of antiapoptotic molecules and allow the cells to survive in interphase. Competition for these ligands declines when T cell numbers are reduced and causes residual naive T cells to proliferate and differentiate into memory-like cells. This memory cell population is thus heterogeneous and comprised of cells derived from responses to both foreign and self-antigens. Typical memory cells are kept alive and induced to divide intermittently by a mixture of IL-7 and IL-15. This review highlights recent advances in how naive and memory T cell homeostasis is regulated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19100699     DOI: 10.1016/j.immuni.2008.11.002

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  558 in total

1.  Naive human T cells are activated and proliferate in response to the heme oxygenase-1 inhibitor tin mesoporphyrin.

Authors:  Trevor D Burt; Lillian Seu; Jeffrey E Mold; Attallah Kappas; Joseph M McCune
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

Review 2.  Plasticity in programming of effector and memory CD8 T-cell formation.

Authors:  Ramon Arens; Stephen P Schoenberger
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

3.  The liver kinase B1 is a central regulator of T cell development, activation, and metabolism.

Authors:  Nancie J MacIver; Julianna Blagih; Donte C Saucillo; Luciana Tonelli; Takla Griss; Jeffrey C Rathmell; Russell G Jones
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

4.  Signal regulatory protein α regulates the homeostasis of T lymphocytes in the spleen.

Authors:  Miho Sato-Hashimoto; Yasuyuki Saito; Hiroshi Ohnishi; Hiroko Iwamura; Yoshitake Kanazawa; Tetsuya Kaneko; Shinya Kusakari; Takenori Kotani; Munemasa Mori; Yoji Murata; Hideki Okazawa; Carl F Ware; Per-Arne Oldenborg; Yoshihisa Nojima; Takashi Matozaki
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

5.  The memory phase of the CD4 T-cell response to influenza virus infection maintains its diverse antigen specificity.

Authors:  Katherine A Richards; Francisco A Chaves; Andrea J Sant
Journal:  Immunology       Date:  2011-03-29       Impact factor: 7.397

6.  Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function.

Authors:  Fany M Iseka; Benjamin T Goetz; Insha Mushtaq; Wei An; Luke R Cypher; Timothy A Bielecki; Eric C Tom; Priyanka Arya; Sohinee Bhattacharyya; Matthew D Storck; Craig L Semerad; James E Talmadge; R Lee Mosley; Vimla Band; Hamid Band
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

7.  CD4+ T cell persistence and function after infection are maintained by low-level peptide:MHC class II presentation.

Authors:  Ryan W Nelson; James B McLachlan; Jonathan R Kurtz; Marc K Jenkins
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

8.  Aged Mice Exhibit Severe Exacerbations of Dry Eye Disease with an Amplified Memory Th17 Cell Response.

Authors:  William Foulsham; Sharad K Mittal; Yukako Taketani; Yihe Chen; Takeshi Nakao; Sunil K Chauhan; Reza Dana
Journal:  Am J Pathol       Date:  2020-04-11       Impact factor: 4.307

9.  Breast milk interleukin-7 and thymic gland development in infancy.

Authors:  Elham M Hossny; Dalia H El-Ghoneimy; Rasha H El-Owaidy; Mohamed G Mansour; Mohammad T Hamza; Amira F El-Said
Journal:  Eur J Nutr       Date:  2019-01-03       Impact factor: 5.614

Review 10.  Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities.

Authors:  Thomas Shum; Robert L Kruse; Cliona M Rooney
Journal:  Expert Opin Biol Ther       Date:  2018-05-14       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.